+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amifostine Market - Global Forecast 2025-2030- Product Image
Amifostine Market - Global Forecast 2025-2030- Product Image
Sale

Amifostine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014936
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Amifostine market is demonstrating sustained momentum as radioprotective agents take on a more integrated role in modern oncology therapies. As cancer treatment approaches become more sophisticated and patient-centric, demand for effective cytoprotection and tailored dosing expands across clinical settings.

Market Snapshot: Amifostine Market Size and Growth

The Amifostine market grew from USD 543.28 million in 2024 to USD 588.46 million in 2025. It is expected to continue growing at a CAGR of 7.93%, reaching USD 859.08 million by 2030. The market’s trajectory reflects increasing adoption in oncology support, adaptation to new treatment modalities, and steady expansion across key global regions.

Scope & Segmentation

This report delivers structured analysis of the Amifostine market, breaking down opportunities, adoption patterns, and delivery channels. It covers a detailed segmentation to ensure stakeholders have actionable insights.

  • Applications: Chemotherapy, Combination Therapy, Radiotherapy
  • End Users: Ambulatory Care Centers, Cancer Clinics, Home Healthcare, Hospitals
  • Indications: Head and Neck Cancer, Lung Cancer, Prostate Cancer
  • Distribution Channels: Direct Tender, Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Route of Administration: Intramuscular, Intravenous, Subcutaneous
  • Dose Regimens: High Dose, Low Dose, Standard Dose
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Key Companies: AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Viatris Inc, Sandoz International GmbH, Fresenius Kabi AG, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Cipla Limited

Key Takeaways for Stakeholders

  • Amifostine remains a vital element in oncology supportive care, notably for its selective tissue-protection advantages as treatment plans evolve.
  • Integrated use in combination regimens and with immune-oncology agents is broadening clinical acceptance and spurring new research into dosing strategies.
  • Evolving guidelines now require rigorous assessment of organ toxicity, boosting demand for advanced radioprotective protocols in both community centers and large hospitals.
  • Growth in ambulatory and home healthcare underscores a shift toward convenience and personalized dosing, while hospitals focus on acute, high-volume administration.
  • Collaborations between leading global manufacturers and local producers are enhancing supply chain stability and enabling flexible fulfilment even in volatile trade environments.
  • Expansion in the Asia-Pacific region is driven by infrastructure investments, emerging research collaborations, and increasing government support for cancer care solutions.

Tariff Impact: Navigating U.S. Trade Policy Shifts

Proposed U.S. tariffs on essential components have required manufacturers to reconsider sourcing and inventory management. To protect operational continuity, companies are renegotiating supplier contracts, implementing strategic stockpiles, and exploring new domestic and international partnerships. Early engagement with regulatory bodies and adaptive procurement strategies are helping to ensure uninterrupted supply and minimize the impact on patient care.

Methodology & Data Sources

This report integrates expert interviews, structured clinical surveys, and insights from oncologists and industry procurement executives. Secondary research draws on peer-reviewed journals, regulatory filings, and patent landscape reviews. Analytical modeling and triangulation validate market size, growth forecasts, and strategic positionings to provide robust, business-driven intelligence.

Why This Report Matters

  • Enables senior leaders to identify actionable growth avenues within evolving cancer therapeutic landscapes and radioprotective applications.
  • Supports strategic planning with clear insight into supply chain risks, changing clinical protocols, and regionally relevant expansion strategies.

Conclusion

The Amifostine market is advancing as a critical component of comprehensive oncology care, responding to emerging clinical needs and logistical challenges. Leaders equipped with this analysis can navigate transformation in treatment, regulation, and sourcing with confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of amifostine for mitigating radiotherapy-induced xerostomia in head and neck cancer patients
5.2. Expansion of generic amifostine approvals boosting cost-effective cytoprotective therapy options in oncology
5.3. Emerging clinical trials evaluating subcutaneous administration of amifostine for outpatient chemotherapy regimens
5.4. Growing interest in combination therapy of amifostine with immune checkpoint inhibitors to reduce chemotherapy toxicities
5.5. Regulatory guidance updates on amifostine labeling impacting pediatric oncology supportive care usage
5.6. Integration of real-world evidence studies assessing long-term safety profiles of amifostine in cancer patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Amifostine Market, by Application
8.1. Introduction
8.2. Chemotherapy
8.3. Combination Therapy
8.4. Radiotherapy
9. Amifostine Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Cancer Clinics
9.4. Home Healthcare
9.5. Hospitals
10. Amifostine Market, by Indication
10.1. Introduction
10.2. Head And Neck Cancer
10.3. Lung Cancer
10.4. Prostate Cancer
11. Amifostine Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.3. Hospital Pharmacy
11.4. Online Pharmacy
11.5. Retail Pharmacy
12. Amifostine Market, by Route Of Administration
12.1. Introduction
12.2. Intramuscular
12.3. Intravenous
12.4. Subcutaneous
13. Amifostine Market, by Dose Regimen
13.1. Introduction
13.2. High Dose
13.3. Low Dose
13.4. Standard Dose
14. Americas Amifostine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Amifostine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Amifostine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AstraZeneca PLC
17.3.2. Teva Pharmaceutical Industries Ltd
17.3.3. Viatris Inc
17.3.4. Sandoz International GmbH
17.3.5. Fresenius Kabi AG
17.3.6. Sun Pharmaceutical Industries Limited
17.3.7. Dr. Reddy’s Laboratories Limited
17.3.8. Hikma Pharmaceuticals PLC
17.3.9. Lupin Limited
17.3.10. Cipla Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. AMIFOSTINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AMIFOSTINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AMIFOSTINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AMIFOSTINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AMIFOSTINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AMIFOSTINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AMIFOSTINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AMIFOSTINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AMIFOSTINE MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AMIFOSTINE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AMIFOSTINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AMIFOSTINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AMIFOSTINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AMIFOSTINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AMIFOSTINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AMIFOSTINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AMIFOSTINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AMIFOSTINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. AMIFOSTINE MARKET: RESEARCHAI
FIGURE 28. AMIFOSTINE MARKET: RESEARCHSTATISTICS
FIGURE 29. AMIFOSTINE MARKET: RESEARCHCONTACTS
FIGURE 30. AMIFOSTINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AMIFOSTINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AMIFOSTINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AMIFOSTINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AMIFOSTINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AMIFOSTINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AMIFOSTINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AMIFOSTINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AMIFOSTINE MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AMIFOSTINE MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AMIFOSTINE MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AMIFOSTINE MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AMIFOSTINE MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AMIFOSTINE MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AMIFOSTINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AMIFOSTINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AMIFOSTINE MARKET SIZE, BY CANCER CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AMIFOSTINE MARKET SIZE, BY CANCER CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AMIFOSTINE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AMIFOSTINE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AMIFOSTINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AMIFOSTINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AMIFOSTINE MARKET SIZE, BY HEAD AND NECK CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AMIFOSTINE MARKET SIZE, BY HEAD AND NECK CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AMIFOSTINE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AMIFOSTINE MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AMIFOSTINE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AMIFOSTINE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AMIFOSTINE MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AMIFOSTINE MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AMIFOSTINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AMIFOSTINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AMIFOSTINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AMIFOSTINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AMIFOSTINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AMIFOSTINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AMIFOSTINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AMIFOSTINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AMIFOSTINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AMIFOSTINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AMIFOSTINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AMIFOSTINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AMIFOSTINE MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AMIFOSTINE MARKET SIZE, BY HIGH DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AMIFOSTINE MARKET SIZE, BY LOW DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AMIFOSTINE MARKET SIZE, BY LOW DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AMIFOSTINE MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AMIFOSTINE MARKET SIZE, BY STANDARD DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS AMIFOSTINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS AMIFOSTINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES AMIFOSTINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES AMIFOSTINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. CANADA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. CANADA AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. CANADA AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. CANADA AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. CANADA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 100. CANADA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 101. MEXICO AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. MEXICO AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. MEXICO AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. MEXICO AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 112. MEXICO AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA AMIFOSTINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 163. GERMANY AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. GERMANY AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. GERMANY AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. GERMANY AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. GERMANY AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. GERMANY AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. GERMANY AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. GERMANY AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 172. GERMANY AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 174. GERMANY AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 175. FRANCE AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. FRANCE AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. FRANCE AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. FRANCE AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. FRANCE AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. FRANCE AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. FRANCE AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. FRANCE AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 184. FRANCE AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 185. FRANCE AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 186. FRANCE AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 199. ITALY AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. ITALY AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. ITALY AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ITALY AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. ITALY AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. ITALY AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. ITALY AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ITALY AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. ITALY AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. ITALY AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. ITALY AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 210. ITALY AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 211. SPAIN AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. SPAIN AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. SPAIN AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SPAIN AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. SPAIN AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. SPAIN AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. SPAIN AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. SPAIN AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. SPAIN AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. SPAIN AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 222. SPAIN AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 259. DENMARK AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. DENMARK AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. DENMARK AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. DENMARK AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. DENMARK AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. DENMARK AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. DENMARK AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. DENMARK AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. DENMARK AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. DENMARK AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 270. DENMARK AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 283. QATAR AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. QATAR AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. QATAR AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. QATAR AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. QATAR AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. QATAR AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. QATAR AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. QATAR AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. QATAR AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. QATAR AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. QATAR AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 294. QATAR AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 295. FINLAND AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. FINLAND AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. FINLAND AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. FINLAND AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. FINLAND AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. FINLAND AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. FINLAND AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. FINLAND AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. FINLAND AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. FINLAND AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. FINLAND AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 306. FINLAND AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 329. NIGERIA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 330. NIGERIA AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 331. EGYPT AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 332. EGYPT AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 333. EGYPT AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. EGYPT AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. EGYPT AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 336. EGYPT AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 337. EGYPT AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. EGYPT AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. EGYPT AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 340. EGYPT AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 341. EGYPT AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 342. EGYPT AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 343. TURKEY AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 344. TURKEY AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 345. TURKEY AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. TURKEY AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. TURKEY AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 348. TURKEY AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 349. TURKEY AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. TURKEY AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. TURKEY AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 352. TURKEY AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 353. TURKEY AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 354. TURKEY AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 355. ISRAEL AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 356. ISRAEL AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 357. ISRAEL AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 358. ISRAEL AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 359. ISRAEL AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 360. ISRAEL AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 361. ISRAEL AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 362. ISRAEL AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 363. ISRAEL AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 364. ISRAEL AMIFOSTINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 365. ISRAEL AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 366. ISRAEL AMIFOSTINE MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 367. NORWAY AMIFOSTINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 368. NORWAY AMIFOSTINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 369. NORWAY AMIFOSTINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 370. NORWAY AMIFOSTINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 371. NORWAY AMIFOSTINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 372. NORWAY AMIFOSTINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 373. NORWAY AMIFOSTINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD M

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Amifostine market report include:
  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc
  • Sandoz International GmbH
  • Fresenius Kabi AG
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy’s Laboratories Limited
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 588.46 Million
Forecasted Market Value ( USD ) by 2030 $ 859.08 Million
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Amifostine (CAS 20537-88-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Amifostine (CAS 20537-88-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Doxorubicin Market - Global Forecast 2025-2030 - Product Image

Doxorubicin Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Capecitabine Tablets Market - Global Forecast 2025-2030 - Product Image

Capecitabine Tablets Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Herceptin Market Size, Share & Trends Analysis Report By Product (Biosimilar, Biologic) By Application (Breast Cancer, Stomach/Gastric Cancer), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Herceptin Market Size, Share & Trends Analysis Report By Product (Biosimilar, Biologic) By Application (Breast Cancer, Stomach/Gastric Cancer), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Keytruda Market Size, Share & Trends Analysis Report By Application (Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Keytruda Market Size, Share & Trends Analysis Report By Application (Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From

About the Amifostine Market

Amifostine is a drug used in the treatment of lung cancer. It is a prodrug, meaning it is converted into an active form in the body. It works by protecting healthy cells from the toxic effects of chemotherapy and radiation therapy. It is administered intravenously and is usually given prior to radiation therapy. It is also used to reduce the risk of kidney damage caused by certain chemotherapy drugs. Amifostine is approved by the US Food and Drug Administration (FDA) for the reduction of kidney damage caused by certain chemotherapy drugs. It is also approved for the protection of healthy cells from the toxic effects of radiation therapy. The market for Amifostine is mainly driven by the increasing prevalence of lung cancer and the growing demand for effective treatments. The increasing awareness of the drug’s benefits is also driving the market. Some of the major companies in the Amifostine market include Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.